I. Kone-Paut Et Al. , "External Validation of the Autoinflammatory Disease Activity Index (AIDAI) in Patients with Colchicine-Resistant FMF, Hids/Mkd, and TRAPS: Results from a Pivotal, Phase 3 Trial of Canakinumab," ARTHRITIS & RHEUMATOLOGY , vol.70, 2018
Kone-Paut, I. Et Al. 2018. External Validation of the Autoinflammatory Disease Activity Index (AIDAI) in Patients with Colchicine-Resistant FMF, Hids/Mkd, and TRAPS: Results from a Pivotal, Phase 3 Trial of Canakinumab. ARTHRITIS & RHEUMATOLOGY , vol.70 .
Kone-Paut, I., Piram, M., Benseler, S., Kuemmerle-Deschner, J. B., Jansson, A. F., Rosner, I., ... Tommasini, A.(2018). External Validation of the Autoinflammatory Disease Activity Index (AIDAI) in Patients with Colchicine-Resistant FMF, Hids/Mkd, and TRAPS: Results from a Pivotal, Phase 3 Trial of Canakinumab. ARTHRITIS & RHEUMATOLOGY , vol.70.
Kone-Paut, Isabelle Et Al. "External Validation of the Autoinflammatory Disease Activity Index (AIDAI) in Patients with Colchicine-Resistant FMF, Hids/Mkd, and TRAPS: Results from a Pivotal, Phase 3 Trial of Canakinumab," ARTHRITIS & RHEUMATOLOGY , vol.70, 2018
Kone-Paut, Isabelle Et Al. "External Validation of the Autoinflammatory Disease Activity Index (AIDAI) in Patients with Colchicine-Resistant FMF, Hids/Mkd, and TRAPS: Results from a Pivotal, Phase 3 Trial of Canakinumab." ARTHRITIS & RHEUMATOLOGY , vol.70, 2018
Kone-Paut, I. Et Al. (2018) . "External Validation of the Autoinflammatory Disease Activity Index (AIDAI) in Patients with Colchicine-Resistant FMF, Hids/Mkd, and TRAPS: Results from a Pivotal, Phase 3 Trial of Canakinumab." ARTHRITIS & RHEUMATOLOGY , vol.70.
@article{article, author={Isabelle Kone-Paut Et Al. }, title={External Validation of the Autoinflammatory Disease Activity Index (AIDAI) in Patients with Colchicine-Resistant FMF, Hids/Mkd, and TRAPS: Results from a Pivotal, Phase 3 Trial of Canakinumab}, journal={ARTHRITIS & RHEUMATOLOGY}, year=2018}